FDA Recalls Cromolyn Sodium Eye Drops Nationwide for Manufacturing Defects
Akorn, Inc. is recalling 188,550 bottles of Cromolyn Sodium Ophthalmic Solution nationwide due to manufacturing quality control deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall with no reported illnesses or injuries. The recall is classified as a voluntary precautionary measure due to manufacturing quality control deviations, fitting the Moderate severity criterion for voluntary precautionary recalls.
Plain-English summary
Akorn, Inc. is recalling Cromolyn Sodium Ophthalmic Solution, USP 4%, in 10mL bottles (NDC 17478-291-11). Approximately 188,550 bottles have been recalled nationwide due to Current Good Manufacturing Practice (CGMP) deviations. Affected lot numbers include 0G75A, 0G12A, 0H50A, 0J88A, 1D98A, 1E31A, 1D97A, and 1H14A, with expiration dates ranging from June 2023 to July 2024.
Patients currently using this medication should contact their healthcare provider or pharmacist before discontinuing use. Medical guidance should be sought to determine the appropriate course of action.
The recalled product
- Product
- Cromolyn Sodium Ophthalmic Solution, USP 4%, 10mL per bottle, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-291-11
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Ophthalmic Solution
- Hazard
- Affected units
- 188,550
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot: 0G75A
- 0G12A
- EXP 6/30/2023
- 0H50A
- EXP 7/31/2023
- 0J88A
- EXP 8/31/2023
- 1D98A
- EXP 3/31/2024
- 1E31A
- EXP 4/30/2024
- 1D97A
- 1H14A
- EXP 7/31/2024
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 27 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 27 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · manufacturing defect
See all →- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-09-09
- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- HighKnee Prosthesis Trial Recall for Manufacturing Defect
FDA (Devices) · 2026-08-12
- HighUSTAR II Knee System Hinge Box Trial Recall
FDA (Devices) · 2026-08-12
- HighU2 Total Knee System Femoral Valgus Adaptor Recall
FDA (Devices) · 2026-08-12